Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/50506| Title: | Comparison between a point-of-care and a laboratory-based CYP2C19*2 genotyping assay for pharmacist-led personalisation of antiplatelet therapy |
| Authors: | Wirth, Francesca Zahra, Graziella Xuereb, Robert G. Barbara, Christopher Fenech, Albert Azzopardi, Lilian M. |
| Keywords: | Blood platelet disorders Blood platelets -- Aggregation Clopidogrel Coronary arteries -- Stenosis Point-of-care testing Cytochrome P-450 CYP2C19 Pharmacists -- Practice |
| Issue Date: | 2015-10 |
| Publisher: | American College of Clinical Pharmacy |
| Citation: | Wirth, F., Zahra, G., Xuereb, R. G., Barbara, C., Fenech, A., & Azzopardi, L. M. (2015, October). Comparison between a point-of-care and a laboratory-based CYP2C19*2 genotyping assay for pharmacist-led personalisation of antiplatelet therapy. ACCP Global Conference on Clinical Pharmacy, San Francisco, USA. e282-e283. |
| Abstract: | PURPOSE: To apply a point-of-care (POC) assay to identify presence of the CYP2C19 loss-of-function (LoF) *2 allele in patients undergoing percutaneous coronary intervention (PCI) and to compare it to a laboratory-based assay. The laboratorybased assay selected uses a reverse hybridisation technique which is reported to be robust and accurate. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/50506 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Comparison_between_a_point_of_care_and_a_laboratory_based_CYP2C19_2_genotyping_assay_2015_poster.pdf | 549.98 kB | Adobe PDF | View/Open | |
| Comparison_between_a_point_of_care_and_a_laboratory_based_CYP2C19_2_genotyping_assay_2015.pdf | 97.17 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.